Analyzing EXACT Sciences (NASDAQ:EXAS) & Auxly Cannabis Group (NASDAQ:CBWTF)

EXACT Sciences (NASDAQ:EXAS) and Auxly Cannabis Group (OTCMKTS:CBWTF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Insider and Institutional Ownership

86.6% of EXACT Sciences shares are held by institutional investors. 2.2% of EXACT Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.


This table compares EXACT Sciences and Auxly Cannabis Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
EXACT Sciences -29.83% -29.06% -12.63%
Auxly Cannabis Group -1,316.81% -29.04% -20.08%

Analyst Recommendations

This is a breakdown of recent recommendations for EXACT Sciences and Auxly Cannabis Group, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EXACT Sciences 0 0 14 0 3.00
Auxly Cannabis Group 0 0 0 0 N/A

EXACT Sciences presently has a consensus price target of $123.62, suggesting a potential upside of 48.93%. Given EXACT Sciences’ higher possible upside, research analysts plainly believe EXACT Sciences is more favorable than Auxly Cannabis Group.

Risk and Volatility

EXACT Sciences has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, Auxly Cannabis Group has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500.

Valuation & Earnings

This table compares EXACT Sciences and Auxly Cannabis Group’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
EXACT Sciences $454.46 million 23.71 -$175.15 million ($1.36) -61.03
Auxly Cannabis Group $580,000.00 517.53 -$51.68 million N/A N/A

Auxly Cannabis Group has lower revenue, but higher earnings than EXACT Sciences.


EXACT Sciences beats Auxly Cannabis Group on 8 of the 11 factors compared between the two stocks.

About EXACT Sciences

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.

About Auxly Cannabis Group

Auxly Cannabis Group Inc. operates as a cannabis streaming company. It provides funding for cannabis production; and holds contractual rights and minority equity interest relating to the operation of cannabis facilities. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.

Receive News & Ratings for EXACT Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EXACT Sciences and related companies with's FREE daily email newsletter.